CARRIE SAMMARCO: Open Payments
NPI 1255358271 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 30 payments from 7 companies in 2025. Trend: 2023 $1,239 · 2024 $2,504 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 5 | $201 |
| TG Therapeutics, Inc. | 7 | $176 |
| Biogen, Inc. | 4 | $160 |
| Novartis Pharmaceuticals Corporation | 4 | $133 |
| Celgene Corporation | 4 | $103 |
| Alexion Pharmaceuticals, Inc. | 4 | $78 |
| Cycle Pharmaceuticals Inc | 2 | $47 |
Products named: BRIUMVI, KESIMPTA, ZEPOSIA, VUMERITY, ULTOMIRIS, TYSABRI, Tascenso ODT, SKYCLARYS.
Industry payments across NY — which companies pay providers there.
